183 related articles for article (PubMed ID: 2892334)
1. Clinical and pathophysiological aspects of somatostatin and the gastrointestinal tract.
Lamers CB
Acta Endocrinol Suppl (Copenh); 1987; 286():19-25. PubMed ID: 2892334
[TBL] [Abstract][Full Text] [Related]
2. The use of somatostatin and its analogs in the treatment of surgical disorders.
Mulvihill S; Pappas TN; Passaro E; Debas HT
Surgery; 1986 Sep; 100(3):467-76. PubMed ID: 2874618
[TBL] [Abstract][Full Text] [Related]
3. Somatostatin--physiological and pathophysiological aspects.
Schusdziarra V
Scand J Gastroenterol Suppl; 1983; 82():69-84. PubMed ID: 6138852
[TBL] [Abstract][Full Text] [Related]
4. Pharmacodynamic effects of Sandostatin in the gastrointestinal tract.
Gyr KE; Meier R
Digestion; 1993; 54 Suppl 1():14-9. PubMed ID: 8103010
[TBL] [Abstract][Full Text] [Related]
5. [Somatostatin and the digestive system. Clinical experiences].
Herszényi L; Mihály E; Tulassay Z
Orv Hetil; 2013 Sep; 154(39):1535-40. PubMed ID: 24058098
[TBL] [Abstract][Full Text] [Related]
6. Future medical prospects for Sandostatin.
Harris AG
Z Gastroenterol; 1990 Sep; 28 Suppl 2():55-60. PubMed ID: 1980778
[TBL] [Abstract][Full Text] [Related]
7. Somatostatin and the gastrointestinal tract.
Tulassay Z
Scand J Gastroenterol Suppl; 1998; 228():115-21. PubMed ID: 9867121
[TBL] [Abstract][Full Text] [Related]
8. The clinical use of somatostatin analogues in the treatment of cancer.
Lamberts SW; Krenning EP; Klijn JG; Reubi JC
Baillieres Clin Endocrinol Metab; 1990 Mar; 4(1):29-49. PubMed ID: 1975166
[TBL] [Abstract][Full Text] [Related]
9. A guide to the clinical use of the somatostatin analogue SMS 201-995 (Sandostatin).
Lamberts SW
Acta Endocrinol Suppl (Copenh); 1987; 286():54-66. PubMed ID: 2892338
[TBL] [Abstract][Full Text] [Related]
10. [Advances in gastrointestinal peptides: somatostatin].
Ubilluz R
Rev Gastroenterol Peru; 1993; 13(3):178-85. PubMed ID: 7910493
[TBL] [Abstract][Full Text] [Related]
11. NIH conference. Somatostatin and somatostatin analogue (SMS 201-995) in treatment of hormone-secreting tumors of the pituitary and gastrointestinal tract and non-neoplastic diseases of the gut.
Gorden P; Comi RJ; Maton PN; Go VL
Ann Intern Med; 1989 Jan; 110(1):35-50. PubMed ID: 2535688
[TBL] [Abstract][Full Text] [Related]
12. Somatostatin: physiology and clinical applications.
Shulkes A
Baillieres Clin Endocrinol Metab; 1994 Jan; 8(1):215-36. PubMed ID: 7907862
[TBL] [Abstract][Full Text] [Related]
13. Somatostatin-producing pancreatic endocrine carcinoma presented as relapsing cholangitis -- a case report.
Marakis G; Ballas K; Rafailidis S; Alatsakis M; Patsiaoura K; Sakadamis A
Pancreatology; 2005; 5(2-3):295-9. PubMed ID: 15849491
[TBL] [Abstract][Full Text] [Related]
14. Pancreatic somatostatinoma with obscure inhibitory syndrome and mixed pathological pattern.
Zhang B; Xie QP; Gao SL; Fu YB; Wu YL
J Zhejiang Univ Sci B; 2010 Jan; 11(1):22-6. PubMed ID: 20043348
[TBL] [Abstract][Full Text] [Related]
15. Non-pituitary actions of somatostatin. A review on the therapeutic role of SMS 201-995 (sandostatin).
Lamberts SW
Acta Endocrinol Suppl (Copenh); 1986; 276():41-55. PubMed ID: 2875590
[TBL] [Abstract][Full Text] [Related]
16. Effect of the somatostatin analogue sandostatin (SMS 201-995) on gastrointestinal, pancreatic and biliary function and hormone release in normal men.
Lembcke B; Creutzfeldt W; Schleser S; Ebert R; Shaw C; Koop I
Digestion; 1987; 36(2):108-24. PubMed ID: 2883060
[TBL] [Abstract][Full Text] [Related]
17. Somatostatin-producing neuroendocrine tumors of the duodenum and pancreas: incidence, types, biological behavior, association with inherited syndromes, and functional activity.
Garbrecht N; Anlauf M; Schmitt A; Henopp T; Sipos B; Raffel A; Eisenberger CF; Knoefel WT; Pavel M; Fottner C; Musholt TJ; Rinke A; Arnold R; Berndt U; Plöckinger U; Wiedenmann B; Moch H; Heitz PU; Komminoth P; Perren A; Klöppel G
Endocr Relat Cancer; 2008 Mar; 15(1):229-41. PubMed ID: 18310290
[TBL] [Abstract][Full Text] [Related]
18. Pharmacodynamic effects of Sandostatin in the gastrointestinal tract.
Gyr KE; Meier R
Metabolism; 1992 Sep; 41(9 Suppl 2):17-21. PubMed ID: 1518430
[TBL] [Abstract][Full Text] [Related]
19. Carcinoid syndrome due to a malignant somatostatinoma.
Ozbakir O; Keleştimur F; Oztürk F; Sözüer E; Unal A; Patiroğlu TE; Güven K
Postgrad Med J; 1995 Nov; 71(841):695-8. PubMed ID: 7494779
[TBL] [Abstract][Full Text] [Related]
20. Treatment of endocrine gastroenteropancreatic tumors with somatostatin analogues.
Fehmann HC; Wulbrand U; Arnold R
Recent Results Cancer Res; 2000; 153():15-22. PubMed ID: 10626286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
